Xylyx Bio

1 follower


Xylyx Bio's platform technology of tissue-specific ECM substrates, clinically relevant data packages, and compound testing services increases predictiveness and informs better decision making in drug discovery, saving precious time and money in the quest to develop lifesaving drugs.

Industries

Employees

11-50

Links

Org chart

Andrea Nye

Collapse
John O'Neill
Chief Scientific Officer
Sue Halligan
Co-Founder
Daniel King
Project Manager